PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

107 Continuous or Intermittent Monitoring of …

1 Medical Policy Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description References Authorization Information Policy History Policy Number: 107 BCBSA Reference Number: NCD/LCD: Local Coverage Determination (LCD): Glucose Monitors (L33822) Related Policies Artificial Pancreas Device Systems, #720 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Continuous Monitoring (ie, long-term) Monitoring of glucose levels in interstitial fluid, including real-time Monitoring , as a technique of diabetic Monitoring , including devices with low glucose suspend (LGS features), may be considered MEDICALLY NECESSARY when the following situations occur, despite use of best practices: Patients with type 1 diabetes that is not adequately controlled (A1c > ) who have demonstrated an understanding of the technology, are motivated to use the device correctly and consistently, are expected to be adherent to a comprehensive diabetes treatment plan supervised by a qualified provider, and are capable of using the device to recognize alerts and alarms; or Patients with type I diabetes who have

5 E10.3533 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral

Tags:

  Types, Monitoring, Continuous, Intermittent, Diabetes, Diabetic, Continuous or intermittent monitoring of, Diabetes mellitus, Mellitus

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of 107 Continuous or Intermittent Monitoring of …

Related search queries